CompletedNCT03450590
Heart Rate Variability and Cardiorespiratory Complications During Ophthalmic Arterial Chemotherapy for Retinoblastoma
Studying Retinoblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Seoul National University Hospital
- Principal Investigator
- Tae Kyong KimSeoul National University Hospital
- Enrollment
- 38 target
- Eligibility
- 20 years · All sexes
- Timeline
- 2018 – 2019
Study locations (1)
- Seoul National University Hospital, Seoul, South Korea
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03450590 on ClinicalTrials.govOther trials for Retinoblastoma
Additional recruiting or active studies for the same condition.